Kiora Pharmaceuticals KPRX
NASDAQ KPRX
$2.57 -0.03 (-1.15%)
As of: Sep 30, 2026 · 9:30 AM EDT

Kiora Pharmaceuticals (KPRX) EV to CFO (2024)

Updated

Kiora Pharmaceuticals' (KPRX) EV to CFO stood at -1.64 in Q4 2024.

Analysis

Kiora Pharmaceuticals (KPRX) EV to CFO (2024) Analysis & Trends

Starting with Q1 2024, Kiora Pharmaceuticals' EV to CFO history includes 4 quarters.

  • Per Business Quant, the preceding three quarters came in at -1.65 (Q3 2024), -2.15 (Q2 2024) and -1.79 (Q1 2024).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Johnson & Johnson 655.56 Bn 574.09 Bn 17.26 Bn
2 AbbVie 470.94 Bn 444.10 Bn 12.70 Bn
3 Merck 367.14 Bn 321.57 Bn 12.21 Bn
4 Novartis Ag 280.33 Bn 236.20 Bn 11.24 Bn
5 Astrazeneca 257.78 Bn 231.34 Bn 12.86 Bn
6 Amgen 226.04 Bn 181.44 Bn 7.24 Bn
7 Gilead Sciences 188.89 Bn 163.01 Bn 6.22 Bn
8 Pfizer 163.75 Bn 110.70 Bn 10.94 Bn
9 Vertex Pharmaceuticals 133.68 Bn 105.69 Bn 2.84 Bn
10 Kiora Pharmaceuticals 16.49 Mn 16.49 Mn -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2024 -1.64
Sep 30, 2024 -1.65
Jun 30, 2024 -2.15
Mar 31, 2024 -1.79
API Access

Kiora Pharmaceuticals EV to CFO API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=ev-to-cfo&ticker=KPRX&period=max&api_key=YOUR_API_KEY